LEADER 01541nmm a2200361 u 4500
001 EB002169238
003 EBX01000000000000001307015
005 00000000000000.0
007 cr|||||||||||||||||||||
008 230807 ||| eng
100 1 |a Hernández Guillamon, Mar 
245 0 0 |a Animal models of cerebral amyloid angiopathy (CAA)  |h Elektronische Ressource  |c Mar Hernández Guillamon 
260 |a London  |b Henry Stewart Talks  |c 2023, 2023 
300 |a 1 streaming video file (34 min.)  |b color, sound 
505 0 |a Contents: Cerebral amyloid angiopathy (CAA) -- Beta-amyloid -- Vascular amyloid deposition -- Transgenic rodent models -- Naturally occurring CAA models -- Interventional models -- Cerebral microhemorrhages -- Smooth muscle loss -- CAA biomarkers 
653 |a Cerebral Hemorrhage 
653 |a Brain / Diseases 
653 |a Animal models in research 
653 |a Amyloid beta-Peptides 
653 |a Models, Animal 
653 |a Biomarkers 
653 |a Cerebral arteries 
653 |a Cerebral Amyloid Angiopathy 
653 |a Brain / Hemorrhage 
653 |a Rodentia 
653 |a Amyloid beta-protein 
041 0 7 |a eng  |2 ISO 639-2 
989 |b HST  |a Henry Stewart Talks 
490 0 |a Cerebral amyloid angiopathy (CAA) 
500 |a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web 
856 4 0 |u https://hstalks.com/bs/5361  |x Verlag  |z Streaming video file 
856 4 2 |u https://hstalks.com/bs/p/1110  |3 Series 
082 0 |a 570